이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cencora 관리

관리 기준 확인 3/4

Cencora's CEO는 Steve Collis, Nov2010 에 임명되었습니다 의 임기는 13.58 년입니다. 총 연간 보상은 $ 17.51M, 8% 로 구성됩니다. 8% 급여 및 92% 보너스(회사 주식 및 옵션 포함). 는 $ 67.62M 가치에 해당하는 회사 주식의 0.14% 직접 소유합니다. 67.62M. 경영진과 이사회의 평균 재임 기간은 각각 5.4 년과 9.1 년입니다.

주요 정보

Steve Collis

최고 경영자

US$17.5m

총 보상

CEO 급여 비율	8.0%
CEO 임기	13.7yrs
CEO 소유권	0.1%
경영진 평균 재임 기간	5.5yrs
이사회 평균 재임 기간	9.2yrs

최근 관리 업데이트

Recent updates

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Jun 30

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Mar 18

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Feb 25

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Feb 07

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Jan 05

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Jan 04

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Dec 15

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Nov 05

Is Cencora (NYSE:COR) A Risky Investment?

Nov 03

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Oct 18

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aug 01

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Jul 28

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Jun 19

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

May 01

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Apr 10

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Mar 02

AmerisourceBergen declares $0.485 dividend

Feb 01

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jan 28

AmerisourceBergen partners with pharmaceutical company Civica

Jan 23

AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?

Jan 13

Does AmerisourceBergen (NYSE:ABC) Deserve A Spot On Your Watchlist?

Jan 10

AmerisourceBergen sued by DoJ over suspicious opioid orders

Dec 29

Walgreens Boots Alliance sells $1.0B in AmerisourceBergen shares; $200M buyback from WBA

Dec 09

CEO 보상 분석

Steve Collis 의 보수는 Cencora 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	US$2b
Dec 31 2023	n/a	n/a	US$2b
Sep 30 2023	US$18m	US$1m	US$2b
Jun 30 2023	n/a	n/a	US$2b
Mar 31 2023	n/a	n/a	US$2b
Dec 31 2022	n/a	n/a	US$2b
Sep 30 2022	US$17m	US$1m	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	n/a	n/a	US$2b
Sep 30 2021	US$15m	US$1m	US$2b
Jun 30 2021	n/a	n/a	-US$4b
Mar 31 2021	n/a	n/a	-US$4b
Dec 31 2020	n/a	n/a	-US$3b
Sep 30 2020	US$14m	US$1m	-US$3b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	n/a	n/a	US$649m
Sep 30 2019	US$11m	US$1m	US$855m
Jun 30 2019	n/a	n/a	US$956m
Mar 31 2019	n/a	n/a	US$930m
Dec 31 2018	n/a	n/a	US$1b
Sep 30 2018	US$12m	US$1m	US$2b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$855m
Dec 31 2017	n/a	n/a	US$979m
Sep 30 2017	US$10m	US$1m	US$364m

보상 대 시장: Steve 의 총 보상 ($USD 17.51M )은 US 시장( $USD 13.47M ).

보상과 수익: Steve 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Steve Collis (63 yo)

13.7yrs

테뉴어

US$17,511,240

보상

Mr. Steven H. Collis, also known as Steve, has been the Chief Executive Officer and President of Cencora, Inc. (formerly known as AmerisourceBergen Corporation) since July 2011 and November 2010 respective...

리더십 팀

이름	위치	테뉴어	보상	소유권
Steven Collis	Chairman	13.7yrs	US$17.51m	0.14% $ 64.2m
James Cleary	Executive VP & CFO	5.7yrs	US$5.45m	0.058% $ 25.7m
Robert Mauch	Executive VP & COO	1.8yrs	US$7.70m	0.012% $ 5.5m
Gina Clark	Executive VP and Chief Communications & Administration Officer	7.1yrs	US$3.17m	0.0067% $ 3.0m
Elizabeth Campbell	Executive VP & Chief Legal Officer	2.8yrs	US$4.03m	0.0042% $ 1.9m
Lazarus Krikorian	Senior VP	12.5yrs	데이터 없음	0.010% $ 4.5m
Bennett Murphy	Senior Vice President of Investor Relations	no data	데이터 없음	데이터 없음
Jennifer Dubas	Senior VP & Chief Compliance Officer	no data	데이터 없음	데이터 없음
Silvana Battaglia	Executive VP & Chief Human Resources Officer	5.5yrs	US$3.48m	0.0063% $ 2.8m
Leslie Donato	Executive VP & Chief Strategy Officer	5yrs	데이터 없음	0.0043% $ 1.9m
Ann Anaya	Senior VP and Chief Diversity Equity & Inclusion Officer	2.5yrs	데이터 없음	데이터 없음
J. Quinn	VP & Corporate Treasurer	no data	데이터 없음	데이터 없음

5.5yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 관리: COR 의 관리팀은 노련하고 경험 (평균 재직 기간 5.4 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Steven Collis	Chairman	13.2yrs	US$17.51m	0.14% $ 64.2m
Lauren Tyler	Independent Director	less than a year	데이터 없음	데이터 없음
Richard Gochnauer	Independent Director	15.8yrs	US$300.10k	0.011% $ 5.1m
Mark M. Durcan	Lead Independent Director	8.8yrs	US$380.05k	0.010% $ 4.4m
Lon Greenberg	Independent Director	11.2yrs	US$332.60k	0.0082% $ 3.7m
Kathleen Hyle	Independent Director	14.2yrs	US$320.10k	0.011% $ 4.7m
Dennis Nally	Independent Director	4.5yrs	US$375.36k	0.0044% $ 1.9m
Ornella Barra	Director	9.5yrs	데이터 없음	0% $ 0
Henry McGee	Independent Director	19.7yrs	US$320.10k	0.0076% $ 3.4m
Werner Baumann	Independent Director	less than a year	데이터 없음	데이터 없음
Lorence Kim	Independent director	1.8yrs	US$397.33k	0.000090% $ 39.9k
Redonda Miller	Independent Director	1.5yrs	US$311.82k	0.00079% $ 350.5k

9.2yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: COR 의 이사회는 경험(평균 재직 기간 9.1 년)으로 간주됩니다.

Cencora 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Chairman notifies of intention to sell stock

Insider exercised options and sold US$3.5m worth of stock

Chairman exercised options and sold US$1.4m worth of stock

Executive VP & COO exercised options and sold US$4.9m worth of stock

Chairman exercised options and sold US$1.6m worth of stock

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Recent updates

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?

Chairman notifies of intention to sell stock

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Insider exercised options and sold US$3.5m worth of stock

Chairman exercised options and sold US$1.4m worth of stock

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

Second quarter dividend of US$0.51 announced

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on May 24, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Cencora, Inc. (NYSE:COR) announces an Equity Buyback for $2,000 million worth of its shares.

Executive VP & COO exercised options and sold US$4.9m worth of stock

Cencora, Inc. to Report Q2, 2024 Results on May 01, 2024

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Cencora Remains Chronically Undervalued, With Material Growth Potential

Chairman exercised options and sold US$1.6m worth of stock

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Cencora, Inc. Reaffirms Guidance for Year 2024

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

First quarter dividend of US$0.51 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 9.0% to US$235

Consensus EPS estimates fall by 14%

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on February 26, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc. to Report Q1, 2024 Results on Jan 31, 2024

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Chairman recently sold US$8.7m worth of stock

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Chairman exercised options and sold US$3.1m worth of stock

Insider recently sold US$2.0m worth of stock

Executive VP & CFO exercised options and sold US$3.1m worth of stock

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Cencora, Inc. Declares Quarterly Dividend, Payable November 27, 2023

Is Cencora (NYSE:COR) A Risky Investment?

Full year 2023 earnings: EPS misses analyst expectations

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Chairman exercised options and sold US$2.7m worth of stock

Cencora, Inc. to Report Q4, 2023 Results on Nov 02, 2023

Insider exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Chairman exercised options and sold US$1.0m worth of stock

Now 21% undervalued

Amerisourcebergen Corporation Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation Declares Quarterly Cash Dividend, Payable on August 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation to Report Q3, 2023 Results on Aug 02, 2023

Insider exercised options and sold US$3.0m worth of stock

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Chairman exercised options and sold US$1.1m worth of stock

TPG Inc. (NasdaqGS:TPG), AmerisourceBergen Corporation (NYSE:ABC) and the management team of OneOncology, Inc. acquired OneOncology, LLC from General Atlantic Service Company, L.P. and others.

Executive VP & Chief Legal Officer recently sold US$731k worth of stock

Chairman exercised options and sold US$966k worth of stock

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

Chairman notifies of intention to sell stock

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Insider exercised options and sold US$54k worth of stock

Insider recently sold US$301k worth of stock

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet